Series C - Alladapt Immunotherapeutics
Investment Firm
Overview
Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy.
Announced Date
Feb 20, 2020
Funding Type
Series C
Highlights
Location
United States, North America
Social
Participant Investors
5
Round Details and Background
Alladapt Immunotherapeutics raised $60000000 on 2020-02-20 in Series C
Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Feb 20, 2020 |  Series C - Alladapt Immunotherapeutics | 9 | - | 60.0M |
| Jun 22, 2022 | Venture Round - Alladapt Immunotherapeutics | 6 | - | 119.0M |
| Aug 30, 2022 | Debt Financing - Alladapt Immunotherapeutics | 1 | - | 50.0M |